Unknown

Dataset Information

0

Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands.


ABSTRACT: The 5-hydroxytryptamine (5-HT1A) receptors represent an attractive target in drug discovery. In particular, 5-HT1A agonists and partial agonists are deeply investigated for their potential role in the treatment of anxiety, depression, ischaemic brain disorder and more recently, of pain. On the other hand, 5-HT1A antagonists have been revealed promising compounds in cognition disorders and, lately, in cancer. Thus, the discovery of 5HT1A ligands is nowadays an appealing research activity in medicinal chemistry. In this work, Comparative Molecular Fields Analysis (CoMFA) and Comparative Molecular Similarity Index Analysis (CoMSIA) were applied on an in-house library of 5-HT1A ligands bearing different chemical scaffolds in order to elucidate their affinity and selectivity for the target. Following this procedure, a number of structural modifications have been drawn for the development of much more effective 5-HT1AR ligands. [Formula: see text].

SUBMITTER: Guariento S 

PROVIDER: S-EPMC6009877 | biostudies-other | 2017 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT<sub>1A</sub> ligands.

Guariento Sara S   Franchini Silvia S   Tonelli Michele M   Fossa Paola P   Sorbi Claudia C   Cichero Elena E   Brasili Livio L  

Journal of enzyme inhibition and medicinal chemistry 20171201 1


The 5-hydroxytryptamine (5-HT<sub>1A</sub>) receptors represent an attractive target in drug discovery. In particular, 5-HT<sub>1A</sub> agonists and partial agonists are deeply investigated for their potential role in the treatment of anxiety, depression, ischaemic brain disorder and more recently, of pain. On the other hand, 5-HT<sub>1A</sub> antagonists have been revealed promising compounds in cognition disorders and, lately, in cancer. Thus, the discovery of 5HT<sub>1A</sub> ligands is nowa  ...[more]

Similar Datasets

| S-EPMC4896471 | biostudies-literature
| S-EPMC8179109 | biostudies-literature
| S-EPMC2659626 | biostudies-literature
| S-EPMC4007967 | biostudies-literature
| S-EPMC6214143 | biostudies-literature
| S-EPMC6733853 | biostudies-literature
| S-EPMC4027751 | biostudies-literature